Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Innocan Pharma Corporation (INNO.CN)

Innocan Pharma Corporation (INNO.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 47,342
  • Shares Outstanding, K 175,343
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 19.29
Trade INNO.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings -0.01 on 06/30/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.150 +93.33%
on 10/08/20
0.300 -3.33%
on 10/14/20
+0.110 (+61.11%)
since 09/23/20
3-Month
0.150 +93.33%
on 10/08/20
0.300 -3.33%
on 10/14/20
+0.080 (+38.10%)
since 07/23/20
52-Week
0.050 +480.00%
on 03/24/20
0.350 -17.14%
on 04/20/20
-0.010 (-3.33%)
since 10/23/19

Most Recent Stories

More News
Innocan Pharma Announces the Publication of Two Studies Supporting Its CLX Therapy for COVID-19 Infected Lung Cells

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 23, 2020) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the "" or ""), is pleased to announce the recent publication of two scientific...

INNO.CN : 0.290 (+7.41%)
Innocan Pharma's Clinical Study in the US Indicates that More than 90% of Participants Experienced Pain Reduction After Using Innocan's Relief &Go OTC Pain Relief Spray

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 19, 2020) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the "" or ""), is pleased to announce today a Clinical Study, conducted by...

INNO.CN : 0.290 (+7.41%)
Innocan Pharma's Cosmetic Clinical Study Indicates a 90% Wrinkle Reduction After Using Its SHIR(TM) Premium CBD Facial Serum

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 15, 2020) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the "" or ""), is pleased to announce today that it has completed a cosmetic...

INNO.CN : 0.290 (+7.41%)
Innocan Achieves Major Milestone in Developing Its Unique CBD-Loaded Liposome Platform Technology for Injectable CBD

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 9, 2020) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the "" or ""), is pleased to announce today that an animal study on mice,...

INNO.CN : 0.290 (+7.41%)
Innocan Pharma to Provide a Corporate Update via Livestream Video

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 8, 2020) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the "" or ""), is pleased to announce that it will provide a corporate update...

INNO.CN : 0.290 (+7.41%)
Innocan Phrama Completes Successful Cosmetic Clinical Studies Demonstrating the Efficacy of Its SHIR(TM) CBD Premium Facial Serum on Skin Hydration

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 15, 2020) -   Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the "" or ""), is pleased to announce today, that it has completed a...

INNO.CN : 0.290 (+7.41%)
Innocan Pharma to Amend Warrants Held by Tamar Technologies Ltd.

Toronto, Ontario--(Newsfile Corp. - September 14, 2020) - Innocan Pharma Corporation (CNSX: INNO) (FSE: IP4) (the "" or ""), announces that its board of directors has agreed to amend the terms of certain...

INNO.CN : 0.290 (+7.41%)
INNO : 0.0619 (-11.57%)
Innocan Pharma Announces Publication of Enterprise Report by Mackie Research

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 3, 2020) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the "Company" or "Innocan"), is pleased to announce that Mackie Research...

INNO.CN : 0.290 (+7.41%)
Innocan to Distribute Its CBD Line of Products in Italy and Switzerland

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 20, 2020) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the "" or ""), is pleased to announce that its wholly owned subsidiary, Innocan...

INNO.CN : 0.290 (+7.41%)
Innocan Engages Endless Sky to Manufacture and Distribute Innocan's CBD Cosmetic Products in Canada

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 11, 2020) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the "Company" or "Innocan"), is pleased to announce that its wholly owned...

INNO.CN : 0.290 (+7.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

2nd Resistance Point 0.287
1st Resistance Point 0.278
Last Price 0.290
1st Support Level 0.263
2nd Support Level 0.257

See More

52-Week High 0.350
Last Price 0.290
Fibonacci 61.8% 0.235
Fibonacci 50% 0.200
Fibonacci 38.2% 0.165
52-Week Low 0.050

See More

Business Summary

InnoCan Pharma Corp is a Canada based company engaged in the research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products. Its brands include Shir and Relief & Go.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar